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Abstract
Background: Maspin is a member of serpin family with tumor suppressing activity. Recent studies
of maspin in animal models strongly support maspin's role as an inhibitor against the growth of
primary tumor sand the process of metastasis. However, the molecular mechanism underlying this
inhibition has not been fully elucidated. In this report, we analyze the effect of maspin on tumor cell
apoptosis under several stress conditions.
Methods: Stable clones overexpressing maspin are established in the mouse mammary tumor
TM40D cells. They are treated with staurosporine, TNF-alpha, and serum starvation. The rates of
cell apoptosis are analyzed by TUNEL assay. Inhibitors against caspase 8 and 9 are used in the
apoptosis assay. Western blot analysis and ribonuclease protection assay (RPA) are performed to
examine the expression of Bcl2 family genes.
Results: We report that maspin expressing tumor cells have increased rate of apoptosis when they
are treated with staurosporine and serum starvation. The effect is not through extracellular
maspin. Maspin-mediated apoptosis is partially blocked by caspase 8 and 9 inhibitors, and is
accompanied by changes in the Bcl-2 family proteins. Maspin-expressing tumor cells have a reduced
level of anti-apoptotic protein Bcl-2, and an increased level of pro-apoptotic protein Bax. The
regulation is not controlled at the transcriptional level but is through selective control of Bcl-2 and
Bax protein stability.
Conclusion: Maspin overexpression modulates tumor cell apoptosis through the regulation of
Bcl2 family proteins. Such change results in an increased release of cytochrome c from
mitochondria, thus the increased apoptosis in maspin-expressing cells. This evidence strongly
suggests that the induction of apoptosis in maspin-overexpressing cells represents a major
mechanism by which maspin inhibits breast tumor progression.
Background
Maspin is a member of serpin family with unique tumor
suppressing activity. Initially identified from normal
mammary epithelial cells, maspin gene is not mutated nor
deleted but is rather transcriptionally down-regulated or
silenced by epigenetic changes in breast cancer [1-5].
Maspin protein made from E.coli, yeast, and insect inhib-
its breast tumor cell migration and invasion [6]. In animal
models, maspin has been found to inhibit angiogenesis in
rat cornea and xenograft models [7], and to inhibit
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mammary tumor progression and metastasis in bitrans-
genic mice [8]. In human breast tissue, maspin is
expressed in both luminal and myoepithelial cells, and it
has been suggested that the maspin-expressing myoepi-
thelial cells form a defensive barrier for the progression
from ductal carcinoma in situ to more invasive carcinoma
[9]. Despite these findings, the molecular mechanism
underlying maspin's inhibition is not well characterized.
Previously, our laboratory showed that overexpression of
maspin in normal mammary gland inhibited alveolar
development during pregnancy through the induction of
mammary cell apoptosis [10]. We also demonstrated that
in mammary tumors isolated from WAP-SV40 TAg and
WAP-maspin bitransgenic mice there was a strong correla-
tion between maspin overexpression and increased apop-
tosis [8], suggesting that maspin might induce tumor cell
apoptosis  in vivo. Jiang et al also showed that maspin
could sensitize MDA-435 mammary tumor cells to apop-
tosis induction with a chemical reagent [11]. Recently, we
have established a new mammary tumor implantation
model to further elucidate the mechanism of maspin-
mediated tumor suppression [12]. We demonstrated that
retrovirus infection of TM40D mammary tumor cells with
maspin significantly blocked tumor growth and metasta-
sis. Using the TM40D mammary tumor cells, we showed
that maspin induced tumor cell apoptosis through trans-
location to mitochondria [13]. Here, we show that
maspin-overexpressing tumor cells display a high rate of
apoptosis when cells are treated with a chemical reagent
staurosporine or under serum starvation. We have shown
that the death signal does not involve the secreted maspin
on cell surface but rather is mediated through the intracel-
lular function of maspin. An intrinsic death signal path-
way is induced which alters the protein level of Bcl-2
family members in maspin-expressing tumor cells.
Methods
Cell line and cell culture
Murine mammary tumor cell line TM40D cells were
infected with retrovirus vector for establishing stable cell
lines as described by Shi et al. [12]. Briefly, human maspin
cDNA was cloned into pS2-GFP, a retroviral vector that
was derived from the pS2 family of retroviral vectors. The
plasmid constructs, pS2-maspin and pS2-blank vector
were transfected into 293T package cells to produce infec-
tive viral particles. The viral supernatants were then
allowed to infect TM40D cells in the presence of Poly-
brene. The transfected cells were then selected in the pres-
ence of 100 µg/ml of zeocin (Invitrogen Co., CA). Cells
were seeded by limiting dilution in 96-well plates. Single
clones of stably transfected cells were transferred to indi-
vidual wells of 24-well plates and cultured in medium
containing 100 µg/ml Zeocin. Individual clones were con-
firmed for the presence of human maspin cDNA by RT-
PCR, immunobloting with maspin polyclonal antibody
and immunofluorescence staining. Two maspin expres-
sion clones were named as TM40D-Mp (16) and TM40D-
Mp (18), respectively. One TM40D cell line infected by
pS2-vector was used as a negative control. All tumor sub-
clones were maintained at 37°C in a humidified 95% O2-
5% CO2 atmosphere in DMEM supplemented with 10%
FBS and L-glutamine.
Maspin immunostaining
For intracellular maspin immunostaining, cells grown on
chamber slides were fixed in 4% paraformaldhyde solu-
tion for 1 hr and were permeabilized with 0.5% NP-40 in
PBS for 30 min. The slides were blocked with 10% normal
horse serum for 1 hour before they were treated with the
primary antibody Abs4A at a dilution of 1:200. The sec-
ondary antibody (Texas red conjugated goat anti-rabbit
antibody, Santa Cruz, CA) was used at a dilution of
1:1000 at room temperature for 1 hour. For cell surface
staining, cells grown on slides were washed with PBS
without Mg++ and Ca++ and blocked with 2% BSA for 1
hr at 4°C. First antibody was used at a dilution of 1:200.
The secondary antibody (Texas red conjugated goat anti-
rabbit antibody, Santa Cruz, CA) was used at a dilution of
1:500 at 4°C for 30 min. Slides were mounted and viewed
under a Leica fluorescence microscope.
Apoptosis induction
TM40D cells were plated on coverslips or 10 cm plates
and cultured to 80% confluence. They were treated by one
of the following procedures: 1) Serum starvation: TM40D
cell lines were cultured under serum free condition for
24–72 hours in D-MEM medium with 0.1% BSA; 2) TNF-
alpha treatment (modified according to Kulik's method)
[14]. Briefly, the cells were incubated in serum-free
DMEM medium for 12 hours, and then were treated with
100 ng/ml TNF-alpha (Sigma) for another 7 hours; 3)
Staurosporine treatment: 1 µM staurosporine was added
to the D-MEM medium with 2.5% FBS for another 4
hours. In conjunction with the above treatments, either
the caspase-8 inhibitor II (Z-IETD-FMK) or caspase-9
inhibitor II (LEHD-CHO) were added into the media at a
concentration of 20 nM.
TUNEL assay
After the various treatments, the cells cultured on cover-
slips were washed with ice-cold PBS and fixed in 4% para-
formaldehyde for 1 hour at 4°C. The TUNEL (Terminal
deoxynucleotidyl transferase-mediated dUTP nick end
labeling) assay was performed according to the manufac-
turer's specifications (Roche). Briefly, cell samples were
fixed with freshly prepared 4% paraformaldehyde solu-
tion for 1 hour. Cells in the coverslips were rinsed with
PBS twice and permeabilized with 0.1% Triton X-100 in
0.1% sodium citrate for 2 min on ice. Following the triton
treatment, 50 µl TUNEL reaction mixture was added toBMC Cancer 2005, 5:50 http://www.biomedcentral.com/1471-2407/5/50
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each sample for 30 min at 37C. The slides were then
rinsed 3 times with PBS and counterstained with DAPI.
The mounted slides were analyzed using fluorescence
microscopy. The quantitation of apoptosis was done by
counting the number of apoptotic positive cells in four
randomly selected fields with a 20 X objective. For anti-
body-blocking assay, TM40D-Mp (18) cells were cultured
at 80% confluence. Cell apoptosis was induced using
staurosporine (1 µM in DMEM) and the anti-maspin anti-
body (AbS4A) was added to the medium at a concentra-
tion of 1:200 or 1:400. Normal fetal bovine serum FBS
(1:25) and rabbit IgG (1:200) were used as negative con-
trols. After 7-hour incubation, cells were fixed and used
for TUNEL assay as described above.
Cytosolic protein extraction and cytochrome c 
immunoblot
Cytochrome c immunoblot was carried out using a mod-
ified protocol of Kluck et al [15]. Cultured cells were
starved in serum-free DMEM medium for 48 hours and
then collected with lysis buffer (1 mM CaCl2, 1 mM
MgCl2, 1% NP-40, 1 µg/ml leupeptin, 1 µg/ml aprotinin,
1 µM PMSF, and 100 µM NaVO4). After the lysis mixtures
were incubated on ice for 20 mins, they were centrifuged
at 14,000 rpm for 15 min. The supernatants were col-
lected and total cytosolic proteins were quantitated by a
Bradford spectrometer. About 80 µg protein was loaded in
a 10% SDS-PAGE gel and transferred to polyvinylidene
difluoride (PVDF) membrane (Bio-rad Laboratories, Rich-
mond, CA) at a constant current of 250 mA for 2 hours.
The membrane was incubated with the primary cyto-
chrome c polyclonal antibody (H-104, Santa Cruz) over-
night at a dilution of 1:500. Horseradish peroxidase-
conjugated anti-rabbit secondary antibody at a 1:1000
dilution was incubated with the membrane for another 1
hour at room temperature. The protein was detected with
enhanced chemiluminescence (Pierce, Rockford, IL) for
autoradiography (Hyperfilm-Pharmacia).
Immunoblot and immunoprecipitation assay for Bcl-2 
family proteins
To determine the changes in the expression of Bcl-2 family
proteins in TM40D cells, cells induced under different
procedures were collected and homogenized in lysis
buffer and were sonicated for 4 times for 5 seconds each
on ice. The lysis mixture was centrifuged at 14,000 rpm for
15 min. Sample protein concentration was measured
using the method of Bradford (Bio-rad). Bax protein level
was determined using conventional Western blot analysis.
For the treatment of cycloheximide (CHX), TM40D-cont
and TM40D-Mp (18) cells were first induced with STS for
1 hour before the addition of CHX (50 µM) at the time of
0, 2, 3, and 4 hrs. Vehicle treated tumor cells for 4 hr were
used as control. Bcl-2 and Bcl-XL protein were determined
by immunoprecipitation assay. Briefly, 1,000 µg of pro-
tein lysis was incubated with 1 µg of anti-Bcl-2 or anti-Bcl-
XL  antibodies overnight at 4°C, respectively. Twenty
microliters of protein A agarose beads (Santa Cruz) were
then added to the mixture for an additional 4 hours at
4°C. Immunoprecipitates were harvested by centrifuga-
tion at 2,500 rpm for 5 min at 4°C. The beads were
washed 5 times in lysis buffer. Pellets were resuspended in
20  µl of 3× SDS samples buffer and heated for gel
electrophoresis.
For Western blot analysis of Bcl-2 family proteins, sam-
ples were run in 15% SDS polyacrylamide gels. The pro-
teins were transferred onto a PVDF membrane (Bio-rad)
and blotted with anti-Bax (1:1000), anti-Bcl-2 (1:1000)
and anti-Bcl-XL (1:500). Horseradish peroxidase-conju-
gated anti-rabbit secondary antibody at a 1:1000 dilution
was incubated with the membrane for another 1 hour at
room temperature. The protein was detected by enhanced
chemiluminescence (Pierce, Rockford, IL) and autoradi-
ography (Hyperfilm-Pharmacia).
Ribonuclease protection assay
For ribonuclease protection assays (RPA), total RNA was
isolated from TM40D-cont and TM40D-Mp cells treated
by staurosporine (1 µM) for 4 hrs. 35S labeled Bcl-2 family
antisense probes were generated by transcription of Bcl-2
family genes using a RPA kit (BD PharMingen, Inc., CA)
in accordance with the manufacturer's instruction. Pro-
tected bands were exposed to an X-ray film and quantified
by phosphoimaging analysis. Relative RNA levels were
obtained by dividing the quantitated volume of the pro-
tected Bcl-2 family gene bands by the volume of either
GPADH or L32 control.
Statistical analysis
The differences of means between groups were assessed by
the Student's t-test. P < 0.05 was considered significant
(two tail analysis). All statistical analysis was performed
using Microsoft office XP Software.
Results
To examine whether maspin is involved in the induction
of tumor cell apoptosis, stable clones with various levels
of maspin expression were selected and analyzed using
semi-quantitative RT-PCR, immunostaining, and Western
blot analyses. As shown in Fig. 1, two maspin expression
clones TM40D-Mp (16) (T16) and TM40D-Mp (18)
(T18), and a negative control subclone TM40D-cont (TC)
were selected for further study. We examined the localiza-
tion of maspin in maspin expressing and control tumor
cells using immunofluorescence staining with an anti-
maspin antibody. T16 and T18 had detectable immunos-
taining signals (B, C, E, and F) while TC did not express
maspin (A, D). Under high magnification, we observed
that maspin immunostaining was abundantly located inBMC Cancer 2005, 5:50 http://www.biomedcentral.com/1471-2407/5/50
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the cytoplasm and on the cell surface (Fig. 1G). T18 cells
had a higher level of maspin expression than T16 cells at
both mRNA and protein levels (Fig. 1H).
TC, T16, and T18 cells were treated with chemical reagent
staurosporine (STS) or TNFα . As shown Fig. 2A, TC, T16,
and T18 cells underwent different levels of apoptosis
when they were treated with STS. Caspase 8 and caspase 9
inhibitors were added to TC and T18 cells treated with STS
and TNFα  [16,17]. In both TC and T18 cells, the rate of
apoptosis in STS-treated cells was inhibited when cells
were treated with caspase 9 and 8 inhibitors, more so in
T18 cells than that in TC cells (Fig. 2B). In contrast, when
TC and T18 cells were induced to apoptosis with TNF-α ,
only caspase 8 inhibitor inhibited tumor cell apoptosis
(Fig. 2C). However, there was no difference in the rate of
apoptosis between T18 and control TC cells when they
were induced with TNF-α  (Fig. 2C).
Serpins can regulate cellular apoptosis through both
extrinsic and intrinsic pathways [18,19]. If maspin is
involved in an extrinsic pathway, it will require that the
death signal be initiated by extracellular maspin protein.
Since maspin is present in both cytoplasm and on the cell
Maspin expression in TM40D stable cell lines Figure 1
Maspin expression in TM40D stable cell lines. Cells were stained with an AbS4A maspin primary antibody and followed by 
Texas-red conjugated secondary antibody. Immunofluorescence staining was carried out using TC (A, C), T16 (B, E), and T18 
cells (C, F). G. High magnification of immunofluorescence staining of T18 (100× oil len) under non-permeabilized condition. 
Arrows indicate cell surface staining of maspin. Nuclei were stained with DAPI (D, E, F, and G). H. Quantitation of maspin 
expression in TC (lane 1), T16 (lane 2), and T18 (lane 3) by RT-PCR and Western blot analysis. L19 serves as a loading control 
for RT-PCR analysis.BMC Cancer 2005, 5:50 http://www.biomedcentral.com/1471-2407/5/50
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surface in TM40D-Mp cells (Fig. 1D), it is possible that
maspin could be secreted and bound to the surface of
tumor cells. One major function of maspin is the inhibi-
tion of tumor cell migration which is mediated through a
cell surface event [20]. One maspin antibody Abs4A acts
as function-blocking reagent in the migration assay [20].
To further determine whether maspin-mediated apoptosis
is through secreted maspin protein, an anti-maspin
AbS4A polyclonal antibody was incubated with T18 cells
that were stimulated for apoptosis with staurosporine. As
shown in Fig 3, AbS4A maspin antibody did not block
STS-induced cell apoptosis at concentrations up to 1 µg/
ml (1:200 dilution), even though the same antibody was
effective at blocking maspin's effects on cell migration at
a much lower dosage (data not shown). This suggests that
secreted maspin from TM40D-Mp cells does not induce
cell apoptosis through secreted maspin acting on the cell
surface.
The Bcl-2 family proteins consist of pro- and anti- apop-
totic proteins that act through mitochondria to regulate
apoptosis through the caspase 9 and cytochrome c path-
way. Since we know that maspin-mediated apoptosis
involves mitochondrial death pathway [13], we examined
the protein level of three key apoptosis proteins in tumor
cells treated under serum starvation. These proteins
Detection of an increased apoptosis in maspin expressing tumor cells in cell culture under the induction of STS and TNF-alpha Figure 2
Detection of an increased apoptosis in maspin expressing tumor cells in cell culture under the induction of STS and TNF-alpha. 
A. TC, T16, and T18 cells in monolayer culture were treated with staurosporine (1 µM) for 4 hrs, and apoptosis rate was 
detected using the TUNEL assay. Note the increased apoptosis in T16 and T18 cells. B, C, Maspin-mediated apoptosis was 
blocked by caspase 9 and caspase 8 inhibitors. B. TC and T18 cells were treated with staurosporine (1 µM, 4 hrs), caspase-8 
inhibitor II (Z-IETD-FMK) and caspase-9 inhibitor II (LEHD-CHO) were used at a concentration of 20 nM. C. TC and T18 cells 
were treated with TNF-alpha (100 ng/ml, 7 hrs), caspase-8 inhibitor II (Z-IETD-FMK) and caspase-9 inhibitor II (LEHD-CHO) 
were used at a concentration of 20 nM. Apoptotic cells were assayed by TUNEL and counted in four randomly selected fields 
under 20 X objective. Bars were from four repeated experiments.BMC Cancer 2005, 5:50 http://www.biomedcentral.com/1471-2407/5/50
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include Bax, a pro-apoptotic protein [21], and the anti-
apoptotic Bcl-2 and Bcl-XL [21-23]. When these cells were
serum starved to induce apoptosis, the levels of anti-apop-
totic proteins such as Bcl-2 and Bcl-XL were too low to be
detected by conventional Western blot analysis. Thus, we
used the method of immunoprecipitation followed by
Western blot analysis to analyze their expression levels.
No difference was detected in Bcl-XL protein between the
maspin expressing T16 and T18 cells, and the control TC
cells (Fig. 4A). However, a decrease was consistently
observed in Bcl-2 level in T16 and T18 cells compared to
TC cells under serum starvation condition (Fig. 4A). The
pro-apoptotic protein Bax could be easily detected when
tumor cells were placed under serum starvation condi-
tion. In contrast to Bcl-2 protein, a dramatic increase in
Bax protein level was observed in T16 and T18 cells com-
pared to TC cells (Fig. 4B). Such increased level of Bax was
not observed when cells were treated with TNF-alpha,
which mediates cell apoptosis through death receptor
rather than the mitochondrial pathway (data not shown).
To determine whether maspin overexpression regulates
the gene expression of Bcl-2 family during apoptosis, a
quantitative ribonuclease protection assay (RPA) was
Maspin mediated apoptosis is not through a cell surface event Figure 3
Maspin mediated apoptosis is not through a cell surface event. T18 cells in monolayer culture were treated with staurosporine 
(1 µM). Maspin blocking antibody AbS4A at two concentrations (from a dilution of 1:200 to 1:400) was added to the cell cul-
ture. After 7 hours incubation, cells were fixed for TUNEL staining and apoptotic cells were counted in four randomly selected 
fields under 20 X objective. Results were from three repeated experiments.BMC Cancer 2005, 5:50 http://www.biomedcentral.com/1471-2407/5/50
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carried out using radiolabeled antisense probes for Bcl-2
family genes (RPA kit, BD PharMingen, Inc., CA), and
RNAs isolated from tumor cells under apoptotic condi-
tion. As shown in Fig. 5, the levels of Bax, Bcl-2, and sev-
eral other Bcl-2 family genes were not changed
significantly between control TC cells and maspin
expressing T16 and T18 cells, suggesting the regulation is
not at the transcription level.
Bcl-2 proteins could be controlled at the level of protein
stability. The decreased level of Bcl-2 in T16 and T18 cells
(Fig. 4) is in line with a previous report demonstrating
Bcl-2 protein was specifically targeted for degradation dur-
ing apoptosis by an ubiquitin-dependent event [24]. Since
T16 and T18 cells have higher level of apoptosis, more
Bcl-2 proteins could be targeted for degradation in protea-
some complex. The Bax level was higher in T16 and T18
cells compared to TC cells (Fig. 4). To determine whether
the increased level of Bax protein in T16 and T18 cells is
due to increased protein stability, cells were induced to
apoptosis with STS along with cycloheximide (CHX),
which prevents new protein synthesis. The level of Bax
protein in TC cells was as stable as that in T18 cells after
CHX treatment for 2, 3, and 4 hrs (Fig. 6A). However, Bax
Changed levels of Bcl-2 family proteins in TC, T16, and T18 tumor cells Figure 4
Changed levels of Bcl-2 family proteins in TC, T16, and T18 tumor cells. A. Analysis of anti-apoptotic Bcl-2 proteins in tumor 
cells. Cells were cultured for 48 hrs in serum starvation condition before they were lysed in cell lysis buffer. Cytosolic proteins 
(1 mg) were immunoprecipitated with Bcl-2 and Bcl-XL monoclonal antibodies overnight at 4°C. The level of Bcl-2 and Bcl-XL 
proteins was detected using a HRP-conjugated anti-mouse secondary antibody. IgG serves as an internal control. Right panel, 
relative level of Bcl-2 and Bcl-XL proteins in TC, T16, and T18 cells. The protein bands were quantitated using a densitometer 
and were normalized to IgG signals. B. Analysis of pro-apoptotic Bax protein in TM40D cells. Cells were induced to apoptosis 
with serum starvation. Cell extracts were run on SDS PAGE gel and immunobloted with anti-Bax and anti-beta-actin antibod-
ies. Beta-actin serves as a loading control. Right panel, relative level of Bax protein in TC, T16, and T18 cells. The protein bands 
were quantitated using a densitometer and were normalized to beta-actin signal.BMC Cancer 2005, 5:50 http://www.biomedcentral.com/1471-2407/5/50
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level was specifically reduced in TC cells untreated with
CHX compared to TC cells that were treated with both STS
and CHX for the same time period (4 hrs). Less Bax
protein was degraded in vehicle treated T18 cells than that
in vehicle treated TC cells.
A change in the level of Bcl-2 family proteins in TC and
T18 cells may increase the sensitivity of cells to apoptotic
signal through their downstream components of mito-
chondrial death pathway. Cytochrome c is a critical com-
ponent of the cascade. In normal condition, cytochrome c
is located in the intermembrane space of mitochondria in
the cell, where it functions as a transducer of electrons in
the respiratory chain. When cells undergo apoptosis, cyto-
chrome c is released into the cytoplasm, which initiates
the mitochondrial death cascade [25]. To further deter-
mine whether maspin regulates the cytochrome c release
from the mitochondria, TM40D-cont and TM40D-Mp
cells were serum starved and the cells were harvested for
both whole cell extracts and cellular fractionations with-
out mitochondria. Both the whole cell and cytosolic frac-
tions were collected for Western blot analysis using an
anti-cytochrome c antibody. As shown in Fig. 6B, the total
amount of cytochrome c in the whole cell extracts of TC
and T18 cells remained at similar level. However, maspin
expressing T18 cells had an increased release of cyto-
chrome c to the cytosolic fraction compared to the TC
cells. This suggests that maspin-mediated apoptosis is
through the caspase 9 and cytochrome c death pathway.
Discussion
We have shown in the past few years that maspin acts as a
tumor suppressor, inhibiting both primary tumor growth
and metastasis in cell culture and animal models. Here,
we provide evidence that maspin is actively involved in
the induction of tumor cell apoptosis.
There are at least two general apoptosis pathways, the
intrinsic and extrinsic pathway. Although maspin protein
is present in cytosol and on the cell surface, the induction
of apoptosis is not mediated by extracellular maspin.
Treatment of maspin expressing T18 cells with STS and an
anti-maspin antibody did not affect the apoptosis rate
(Fig. 3). This data is in line with a previous report by Jiang
et al. which showed that exogenous maspin failed to sen-
sitize human breast tumors to chemical induced apopto-
sis [11]. This implicates that intracellular maspin is
actively affecting cell apoptosis, which is supported by our
Expression profile of Bcl-2 family genes in TC, T16, and T18 tumor cells Figure 5
Expression profile of Bcl-2 family genes in TC, T16, and T18 tumor cells. A. Ribonuclease protection assay (RPA) for Bcl-2 fam-
ily genes. Antisense radiolabeled multiprobes were prepared using a RPA kit for detection of Bcl-2 family genes. B. Relative 
level of Bcl-2 family genes quantitated using a densitometer. Results are from three RPA experiments. Error bars represent 
standard deviation. No significant difference (p >> 0.05, t-test) in the expression of any Bcl-2 family genes was observed for 
TM40D-cont (TC), and TM40D-Mp (T16, T18) cells.BMC Cancer 2005, 5:50 http://www.biomedcentral.com/1471-2407/5/50
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report of translocation of intracellular maspin to the mito-
chondria [13]. Our data also confirmed that in maspin
expressing T16 and T18 cells, the Bcl-2 level was decreased
and the level of pro-apoptotic protein Bax was signifi-
cantly increased compared to control TC cells. Such regu-
lation was selectively controlled since another Bcl-2
family protein Bcl-Xl was not affected (Fig. 4A). The effect
of maspin on cell apoptotic machinery was not preexist-
ing since both TC and T18 cells had similar, low level of
apoptosis in high serum medium. Second, the levels of
Bax and caspase 3 were similar before the cells were
treated under serum starvation or with STS (data not
shown). However, their levels were changed under stress
treatment, indicating that the change is dependent on cell
death stimulation. The regulation of Bcl-2 genes by
maspin was not at the transcriptional level (Fig. 5A).
Rather, the stability of these proteins was affected by
maspin. Others have shown that Bcl-2 protein was
Maspin regulates the stability of Bcl-2 family proteins and the release of cytochrome c from mitochondria Figure 6
Maspin regulates the stability of Bcl-2 family proteins and the release of cytochrome c from mitochondria. A. Bax stability in 
TM40D cells. TC and T18 cells were induced with STS (1 µM) for 1 hour before they were treated by CHX (50 µM) for 0, 2, 
3, and 4 hours. DMSO was used as a vehicle control (-CHX, 4 hrs). β -actin was used as a loading control. B. Release of cyto-
chrome c protein from mitochondria to cytosol. TC, T16, and T18 tumor cells were treated with serum starvation for 48 hrs 
before they were harvested for preparation of cell extract and for cellular fractionation. Mitochondria were removed from 
cytosolic fraction by centrifugation. Both whole cell extracts and cytosolic fractions were subjected to Western blot analysis 
using antibodies against cytochrome c and beta-actin. β -actin was used as a loading control.BMC Cancer 2005, 5:50 http://www.biomedcentral.com/1471-2407/5/50
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dephosphorylated and targeted to ubiquitin-dependent
degradation during apoptosis in HUVEC cells [24]. Phos-
phorylation of Bcl-2 confers resistance against induction
of apoptosis. Since Bcl-2 controls the activation of caspase
cascade by its interaction with Bax and by participation in
apoptosome ensemble, degradation of Bcl-2 may unleash
the inhibitory function of Bcl-2 over the apoptosome
[26]. The unexpected finding is that the pro-apoptotic Bax
was stabilized in the presence of maspin through an
unknown mechanism. When new protein synthesis was
inhibited by cycloheximide, including those proteins con-
trol protein degradation, Bax protein was as stable in TC
cells as in maspin expressing T18 cells. Such event of
ordered degradation of proteins happens for the regula-
tion of p53 protein during the cell cycle control [27,28]. It
is possible that when T16 and T18 cells were induced for
apoptosis, more Bax protein might oligomerize and trans-
locate to mitochondria [29,30], which might make the
protein less susceptible for degradation in the cytosol.
However, in control TC cells treated under apoptotic
stress, less Bax proteins might oligomerize and move to
mitochondria and thus were more sensitive to degrada-
tion in the cytosol. A recent study from my laboratory
showed that during maspin-mediated apoptosis, there
was also an increased translocation of maspin from the
cytoplasm to the mitochondria [13]. Whether there is any
connection between Bax and maspin translocation during
apoptosis remains to be tested.
The finding that maspin-induced apoptosis was partially
blocked by both caspase 8 and caspase 9 inhibitor is inter-
esting. Several other reports also show that certain rea-
gents including STS can induce caspase 3 activity and
apoptosis through both the activation of caspase 8 and
caspase 9 [31-35]. In addition, there are numerous reports
demonstrating the cross-talk between caspase 8 and 9
[36,37]. At the moment, no data suggest that maspin-
mediated apoptosis is connected to the death receptor
pathway. Rather, our previous report and this study dem-
onstrate that at least the mitochondrial mediated apopto-
sis pathway is involved [13]. Finally, our data also indicate
that the increased apoptosis in maspin expressing cells is
due to changes in Bcl-2 family protein level. Due to the
changed level of Bcl-2 proteins, the apoptotic pathway
became more active in maspin-expressing cells and more
cytochrome c proteins were released from mitochondria
to the cytosol (Fig. 5B). In many cancers, the anti-apop-
totic protein Bcl-XL  and Bcl-2 are found to be over-
expressed while the activity of pro-apoptotic Bax is coun-
terbalanced by strong surviving signals [38]. Our finding
suggests that one of the functions that maspin plays is to
change the level of Bcl-2 family proteins in tumor cells. It
is noted that the increased apoptosis mediated by maspin
was observed under both serum starvation and chemical
drug induction, confirming that the existence of a general
mechanism of action through the intracellular, mitochon-
dria death pathway. Such findings offer a new direction
for cancer therapy. Identifying the molecular mechanism
of maspin-mediated apoptosis will help us to design bet-
ter reagents for maspin-based therapeutic interventions
against breast cancer.
Conclusion
Overexpression of maspin in mouse mammary tumor
cells increased the rate of tumor cell apoptosis when they
were treated with STS or serum starvation. Maspin-medi-
ated apoptosis could be partially blocked by caspase 9 and
caspase 8 inhibitors. The effect was not through extracel-
lular maspin. Maspin overexpression in breast tumor cells
regulated the level of Bcl-2 family proteins. Maspin-
expressing T16 and T18 cells had a reduced level of anti-
apoptotic protein Bcl-2 but an increased level of pro-
apoptotic protein Bax compared to control TC tumor
cells. Such regulation occurred at the level of protein
stability. The change in Bcl-2 family proteins resulted in
an increased release of cytochrome c from mitochondria,
thus the increased apoptosis in maspin-expressing tumor
cells.
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